Regarding T cell-mediated immunity, it remained stable after two doses of the monovalent Wuhan-based vaccine and was not significantly enhanced by further booster doses or Omicron breakthrough infections (82), suggesting that T cell responses are more antigenically resilient to Spike mutations and continue to contribute to protection against severe COVID-19. Here, CHMP5 is linked to COVID-19.